Cargando…
Profile of trifluridine/tipiracil hydrochloride in the treatment of metastatic colorectal cancer: efficacy, safety, and place in therapy
TAS-102, with its robust survival efficacy and feasible toxicity, is one of the standard salvage-line treatments for patients with metastatic colorectal cancer (mCRC). No definitive data are available to determine which drug should be administered first during salvage-line treatment. Therefore, it i...
Autores principales: | Sunakawa, Yu, Izawa, Naoki, Mizukami, Takuro, Horie, Yoshiki, Hirakawa, Mami, Arai, Hiroyuki, Ogura, Takashi, Tsuda, Takashi, Nakajima, Takako Eguchi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5608085/ https://www.ncbi.nlm.nih.gov/pubmed/28979148 http://dx.doi.org/10.2147/OTT.S106101 |
Ejemplares similares
-
Early morphological change for predicting outcome in metastatic colorectal cancer after regorafenib
por: Arai, Hiroyuki, et al.
Publicado: (2017) -
Biomarkers of Trifluridine-Tipiracil Efficacy
por: Voutsadakis, Ioannis A.
Publicado: (2021) -
Clinical utility of geriatric assessment tools in older patients with gastrointestinal cancer
por: Doi, Ayako, et al.
Publicado: (2023) -
Inferior mesenteric arteriovenous fistula during treatment with bevacizumab in colorectal cancer patient: A case report
por: Doi, Ayako, et al.
Publicado: (2020) -
Retrospective cohort study of trifluridine/tipiracil (TAS-102) plus bevacizumab versus trifluridine/tipiracil monotherapy for metastatic colorectal cancer
por: Kotani, Daisuke, et al.
Publicado: (2019)